Drug search by name

Methylphenidate Extended-Release Oral-Disintegrating Tablets and Seizures disorders

Result of checking the interaction of drug Methylphenidate Extended-Release Oral-Disintegrating Tablets and disease Seizures disorders for safety when used together.

Check result:

Methylphenidate Extended-Release Oral-Disintegrating Tablets <> Seizures disorders

Relevance: 23.07.2019 Reviewer: Shkutko P.M., M.D., in

When checking interaction based on authoritative sources Drugs.com, Rxlist.com, Webmd.com, Medscape.com there are contraindications or side effects that may cause harm or increase the negative effect from drug use in presence of concomitant diseases.

Consumer:

There is some clinical evidence that methylphenidate may lower the seizure threshold, occasionally even in patients without a history of seizures or prior EEG abnormalities. Therapy with methylphenidate (racemic) or dexmethylphenidate (the more pharmacologically active d-enantiomer) should be administered cautiously in patients with or predisposed to seizures. The medication should be discontinued if seizures occur during its use.

References:

"Product Information. Ritalin (methylphenidate)." Novartis Pharmaceuticals, East Hanover, NJ.
"Product Information. Focalin (dexmethylphenidate)." Mikart Inc, Atlanta, GA.

Methylphenidate Extended-Release Oral-Disintegrating Tablets

Generic Name: methylphenidate

Brand Name: Adhansia XR, Aptensio XR, Concerta, Cotempla XR-ODT, Jornay PM, Metadate CD, Metadate ER, Methylin, QuilliChew ER, Quillivant XR, Relexxii, Ritalin, Ritalin LA, Ritalin SR, Daytrana, Methylin ER

Synonyms: Methylphenidate

What is Methylphenidate Extended-Release Oral-Disintegrating Tablets?